<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
<channel>
	<generator>Vivvo CMS 4.1</generator>
	<title>PRI: Public Radio International</title>
	<link>http://www.pri.org/</link>
	<copyright>&amp;copy;2010 Spoonlabs d.o.o.</copyright>
	<image>
		<title>PRI: Public Radio International</title>
		<url>http://www.pri.org/files.php?file=rss_682409203.gif</url>
		<link>http://www.pri.org/</link>
	</image>
	
			
				
					<item>
						
							<title>Public gets mixed messages regarding efficacy of Avastin for treating breast cancer</title>
							<link>http://www.pri.org/stories/health/public-gets-mixed-messages-regarding-efficacy-of-avastin-for-treating-breast-cancer-7099.html</link>
							<category>Health and Medicine</category>
							<pubDate>Tue, 22 Nov 2011 10:39:00 -0600</pubDate>
							<description>Late last week, the FDA ruled that Avastin could no longer be marketed as treatment for breast cancer. But Medicare and virtually all private insurance providers will continue to pay for just that use of the drug. It&amp;#039;s a mixed message that has raised some eyebrows.</description>
							
						
					</item>
					
							
						
				
			
		




<description>PRI: Public Radio International</description>
</channel>
</rss>